BeiGene, Ltd. (BGNE)


BeiGene, Ltd. (BGNE)

$135.52 USD

2.57 (1.93%)

Updated Sep 20 12:00am

Add BGNE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 216 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

BGNE Daily Price Range
BGNE 52-Week Price Range

BGNE Stock Chart More Charts


BGNE Price/Volume Stats

Current price $135.52
Prev. close $132.95
Day low $132.03
Day high $137.86
50-day MA $134.29
200-day MA $131.93
52-week high $179.57
52-week low $105.19
Volume 423,500
Avg. volume 320,020
Dividend yield N/A
Market Cap 6.43B

BeiGene, Ltd. (BGNE) Company Bio


BeiGene, Ltd., a clinical-stage biopharmaceutical company, discovers and develops various oncology drugs in the People’s Republic of China. The company was founded in 2010 and is based in the Cayman Islands.





BGNE News Stream


Event/Time News Detail
Loading, please wait...

BGNE Social Stream


Loading social stream, please wait...

View Full BGNE Social Stream

BGNE Returns

1-mo -5.85%
3-mo 11.65%
6-mo 7.54%
1-year -17.35%
3-year 337.44%
5-year N/A
YTD -3.38%
2018 43.53%
2017 221.87%
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4293 seconds.